Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.
published in: Vaccine
date of publication: 2015-12-22
language: English
main subject: Rift Valley fever phlebovirus, attenuated vaccine, Rift Valley fever
Cites articles 28
- 2005-12-01
- 1993-11-01
Date
Title
Article - wd:Q40124756